[Apolipoproteins are better risk markers than conventional lipids].
Walldius
Göran
G
Konung Gustaf V:s forskningsinstitut, Solna, AstraZeneca AB, Södertälje. goran.walldius@astrazeneca.com
Holme
Ingar
I
Jungner
Ingmar
I
D000328:Adult; D000368:Aged; D016632:Apolipoprotein A-I / Q000097:blood; D001053:Apolipoproteins / Q000097:blood*; D001055:Apolipoproteins B / Q000097:blood; D035843:Biomedical Research; D002318:Cardiovascular Diseases / Q000097:blood*; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
D016632:Apolipoprotein A-I; D001053:Apolipoproteins; D001055:Apolipoproteins B; D008055:Lipids